Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 21 | Yaacobi TalDirector | Open-market sale | SELL | $1,554 1,400 sh | Apr 1, 2026 traded Mar 30, 2026 | |
Mat IshbiaDirector, President and CEO, 10% Owner |
Open-market sale · 10b5-1 plan |
| SELL |
| $3.55M 1.00M sh |
| Apr 1, 2026 traded Mar 31, 2026 |
| 19 | Dandekar AtulCSBO | Open-market sale · 10b5-1 plan | SELL | $196K 6,710 sh | Apr 1, 2026 traded Mar 30, 2026 |
| 19 | Savitz RyanEVP, CFO & CBO | Open-market sale · 10b5-1 plan | SELL | $1.72M 21.8K sh | Apr 1, 2026 traded Mar 31, 2026 |
| 16 | Mat IshbiaDirector, President and CEO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $3.63M 1.00M sh | Apr 1, 2026 traded Apr 1, 2026 |
| 14 | Ugwumba Chidozie10% Owner | Open-market sale | SELL | $21K 4,278 sh | Apr 1, 2026 traded Apr 1, 2026 |
| 12 | Brady James AloysiusDirector | Open-market sale · 10b5-1 plan | SELL | $60K 10.8K sh | Apr 1, 2026 traded Mar 30, 2026 |
| 12 | Dandekar AtulCSBO | Open-market sale · 10b5-1 plan | SELL | $24K 790 sh | Apr 1, 2026 traded Mar 30, 2026 |
| 9 | Savitz RyanEVP, CFO & CBO | Open-market sale · 10b5-1 plan | SELL | $65K 800 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 9 | Savitz RyanEVP, CFO & CBO | Open-market sale · 10b5-1 plan | SELL | $196K 2,366 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 9 | Savitz RyanEVP, CFO & CBO | Open-market sale · 10b5-1 plan | SELL | $109K 1,390 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 9 | Savitz RyanEVP, CFO & CBO | Open-market sale · 10b5-1 plan | SELL | $119K 1,485 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 8 | Yi StevenDirector, See Remarks | Open-market sale · 10b5-1 plan | SELL | $37K 4,000 sh | Apr 1, 2026 traded Apr 1, 2026 |
| 8 | Bird Justin ChristopherExecutive Vice President | Open-market sale · 10b5-1 plan | SELL | $109K 1,128 sh | Apr 1, 2026 traded Apr 1, 2026 |
| 3 | Yi StevenDirector, See Remarks | Open-market sale · 10b5-1 plan | SELL | $38K 4,000 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 3 | Yi StevenDirector, See Remarks | Open-market sale · 10b5-1 plan | SELL | $37K 4,000 sh | Apr 1, 2026 traded Mar 30, 2026 |
| 1 | Pena Fernando AustinDirector, President | Open-market sale · 10b5-1 plan | SELL | $31K 1,666 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 50 | Weaver Robert S.EVP, Government Relations | Open-market sale | SELL | $399K 1,872 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 50 | Morgan RachelEVP General Counsel | Open-market sale | SELL | $668K 3,127 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 47 | Lamattina John LDirector | Open-market sale | SELL | $434K 2,161 sh | Mar 31, 2026 traded Mar 6, 2026 |
| 44 | Degner DennisChief Executive Officer & Pres | Open-market sale | SELL | $693K 15.0K sh | Mar 31, 2026 traded Mar 30, 2026 |
| 40 | Preston Tracy MEVP, CLO & Corporate Secretary | Open-market sale | SELL | $49K 2,736 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 40 | Mark AlfordRSelf | Partial sale | SELL | $1,001 – $15K | Mar 31, 2026 traded Mar 16, 2026 |
| 39 | Weitman GarySee Remarks | Open-market sale | SELL | $214K 1,005 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 39 | Bron OlivierCEO, Bloomingdale's | Open-market sale | SELL | $54K 3,051 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 36 | McDowell Erin WSVP & General Counsel | Open-market sale | SELL | $396K 8,250 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 35 | Manor SagitCFO | Open-market sale | SELL | $69K 1,252 sh | Mar 31, 2026 traded Mar 31, 2026 |
| 35 | Szabo ShandellDirector | Open-market sale | SELL | $375K 11.7K sh | Mar 31, 2026 traded Mar 30, 2026 |
| 33 | Manning MeredithChief Commercial Officer | Open-market sale | SELL | $146K 4,864 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 33 | Huang Michael F.Sr. VP of Clinical Development | Open-market sale | SELL | $128K 4,256 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 32 | Tepper OrenCRO | Open-market sale | SELL | $3,991 74 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 32 | Furman Carly LisanneCEO NAYX North America | Open-market sale | SELL | $17K 313 sh | Mar 31, 2026 traded Mar 31, 2026 |
| 30 | Garagic DenisCHIEF TECHNOLOGY OFFICER | Open-market sale | SELL | $84K 15.1K sh | Mar 31, 2026 traded Mar 30, 2026 |
| 29 | Manning MeredithChief Commercial Officer | Open-market sale | SELL | $65K 2,100 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 29 | Huang Michael F.Sr. VP of Clinical Development | Open-market sale | SELL | $57K 1,838 sh | Mar 31, 2026 traded Mar 27, 2026 |
| 29 | Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $356K 44.0K sh | Mar 31, 2026 traded Mar 30, 2026 |
| 27 | Sonne StephenCHIEF LEGAL OFFICER | Open-market sale | SELL | $19K 3,471 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 27 | Thatcher TrevorCHIEF FINANCIAL OFFICER | Open-market sale | SELL | $17K 3,030 sh | Mar 31, 2026 traded Mar 30, 2026 |
| 26 | Lentell EricChief Legal & Strategy Officer | Open-market sale · 10b5-1 plan | SELL | $268K 50.0K sh | Mar 31, 2026 traded Mar 26, 2026 |
| 26 | Manning MeredithChief Commercial Officer | Open-market sale | SELL | $18K 558 sh | Mar 31, 2026 traded Mar 27, 2026 |